Geneos Wealth Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-440
Closed -$12K 2919
2021
Q2
$12K Hold
440
﹤0.01% 2146
2021
Q1
$13K Hold
440
﹤0.01% 2279
2020
Q4
$11K Buy
+440
New +$5.43K ﹤0.01% 2198

Other funds holding RNLX

Geneos Wealth Management's RNLX Position: Q3 2021 in Review

Geneos Wealth Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2021, closing a stake of 440 shares — an estimated $12K sold.

Geneos Wealth Management first reported a position in RNLX in Q4 2020 and held it in 3 quarters. The position peaked at $13K in Q1 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q3 2021.

  • Geneos Wealth Management reported no remaining Renalytix plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 440 Renalytix plc American Depositary Shares shares in Q3 2021, an estimated $12K.
  • Geneos Wealth Management first reported a position in Renalytix plc American Depositary Shares in Q4 2020 and held it in 3 quarters.
  • Geneos Wealth Management's Renalytix plc American Depositary Shares position peaked at $13K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2021.

Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.